Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

634 ARTÍCULOS , VIENDO DEL 331 AL 345

Targeting of PCSK9 in the Management of Alzheimer's Disease: Expanding the New Potential Key Player

Alanazi M, Al-Kuraishy HM, Hussain NR, Waheed HJ, Al-Gareeb AI, Albuhadily AK, Waheeb TS, Batiha GE.

Drug Dev Res. 2026 Apr;87(2):e70231. doi: 10.1002/ddr.70231.

Unraveling the molecular mechanisms of aluminium chloride-induced Alzheimer's disease

Paul R, Firdous SM.

Biometals. 2026 Apr;39(2):539-564. doi: 10.1007/s10534-026-00788-9. Epub 2026 Jan 21.

Targeting Amyloid Beta Aggregation and Neuroinflammation in Alzheimer's Disease: Advances and Future Directions

Dagla I, Gkikas F, Gikas E, Tsarbopoulos A.

Cells. 2026 Feb 4;15(3):295. doi: 10.3390/cells15030295.

Plant-derived bioactive compounds modulate the gut microbiota in Alzheimer's disease: Metabolite signaling, neuroimmune circuits, and systems-level regulation

Xue D, Hu X, Li R, Sun T, Qian S, Chu F, Gao H, Li F, Cai B.

Phytomedicine. 2026 Apr;153:157919. doi: 10.1016/j.phymed.2026.157919. Epub 2026 Feb 3.

Beyond the streetlight: a TREAT-AD perspective on where to find new Alzheimer's targets

Cary GA, Wiley JC, Carter GW, Levey AI.

Alzheimers Dement. 2026 Feb;22(2):e71142. doi: 10.1002/alz.71142.

Lithium and the Brain-Bone Axis: A Bridge between Osteoporosis and Alzheimer's Disease

Lee JW, Hasegawa T, Ikedo A, Mizuno K, Amizuka N, Kong SW.

Curr Osteoporos Rep. 2026 Feb 10;24(1):7. doi: 10.1007/s11914-026-00954-5.

Alzheimer's disease: Current therapeutic strategies and emerging perspectives for multifactorial intervention

de Melo Silva JG, de Medeiros Barros W, Lopes NMCP, Bellozi PMQ.

Prog Neuropsychopharmacol Biol Psychiatry. 2026 Mar 20;145:111640. doi: 10.1016/j.pnpbp.2026.111640. Epub 2026 Feb 10.

Targeting Alzheimer's pathophysiology with carbon dots: from mechanisms to therapy

Tripathi S, Singh R, Jaiswal S, Sethi M, Rana R, Mishra K, Chourasia MK.

J Mater Chem B. 2026 Jan 14;14(2):389-422. doi: 10.1039/d5tb02134k.

NLRP3 inflammasome and Alzheimer's disease: bridging inflammation and neurodegeneration

Wasim R, Azmi S, Ahmad A, Srivastava A.

Inflammopharmacology. 2026 Feb;34(2):951-966. doi: 10.1007/s10787-025-02092-3. Epub 2026 Jan 5.

Synergistic potential of TREM2 agonists and exercise training in Alzheimer's disease

Zhang J, St Pierre Schneider B, Muguerza E, Chung E, Hsu CG.

Am J Physiol Endocrinol Metab. 2026 Mar 1;330(3):E298-E308. doi: 10.1152/ajpendo.00124.2025. Epub 2026 Jan 6.

Engineering nanobodies for drug delivery systems in Alzheimer's disease

Jootar T, Hongeng S, Chiangjong W.

Artif Cells Nanomed Biotechnol. 2026 Dec;54(1):104-118. doi: 10.1080/21691401.2026.2617707. Epub 2026 Jan 22.

Smart Biosensing Nanomaterials for Alzheimer's Disease: Advances in Design and Drug Delivery Strategies to Overcome the Blood-Brain Barrier

Rajkumar M, Tian F, Javed B, Prajapati BG, Deepak P, Girigoswami K, Karmegam N.

Biosensors (Basel). 2026 Jan 21;16(1):66. doi: 10.3390/bios16010066.

Targeting the Gut Microbiota: Mechanistic Investigation of Polyphenol Modulation of the Gut-Brain Axis in Alzheimer's Disease

Wang Z, Ba S, Li M, Wei Y, Wang Y, Mao J, Xiang Y, Qin D, Zeng C.

Int J Mol Sci. 2026 Jan 7;27(2):604. doi: 10.3390/ijms27020604.

Unrevealing role of TLRs/NLRP receptors in halting Alzheimer's neuroinflammation: Current progress and existing therapies

Upadhayay S.

Int Immunopharmacol. 2026 Mar 15;173:116285. doi: 10.1016/j.intimp.2026.116285. Epub 2026 Jan 29.

Alzheimer's Disease: Evolving Therapeutics, Scientific Progress, and Key Challenges

K SY, Goswami AK, Prasad MR, Chauhan VS, Yadav N.

J Med Chem. 2026 Feb 26;69(4):3693-3718. doi: 10.1021/acs.jmedchem.5c02468. Epub 2026 Feb 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias